Metabolic basis of high density lipoproteins and apolipoprotein A-I increase by HMG-CoA reductase inhibition in healthy subjects and a patient with coronary artery disease

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

Richard J. Havel, Howard A. Eder, Joseph H. Bragdon · Journal of Clinical Investigation · 1955 · 8.8K citations · Full text

Life Sciences, Biochemistry, Chemistry +15

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Anders Olsson, John J.V. McMurray, G Thorgeirsson et al. · The Lancet · 1994 · 8.5K citations

Medicine, Cardiology, Pharmacotherapy +13

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

Frank M. Sacks, Marc A. Pfeffer, Lemuel A. Moyé et al. · New England Journal of Medicine · 1996 · 7.5K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

James Shepherd, Stuart M. Cobbe, Ian Ford et al. · New England Journal of Medicine · 1995 · 7.5K citations · Full text

Medicine, Cardiology, Pharmacotherapy +12

High density lipoprotein as a protective factor against coronary heart disease

Tavia Gordon, William P. Castelli, Marthana C. Hjortland et al. · The American Journal of Medicine · 1977 · 5.1K citations

Medicine, Cardiology, Preventive Medicine +16